PetLife is a registered U.S. veterinary pharmaceutical company bringing its new, scientifically proven, non-toxic, high potency bioactive nutraceuticals and prescription medication to the world of veterinary oncology – with the ultimate goal of preventing cancer, extending the life of pets suffering from cancer while improving their quality of life. PetLife has developed and is launching a new generation of high potency veterinary cancer medications and nutraceuticals for companion pets: Escozine for Pets™. For more information, visit the company’s website at www.petlifepharma.com